+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GUFICBIO

Gufic BioSciences Share Price

₹422.25 -17.6 (-4%)
57.56% Gain from 52W Low

18 Nov, 2026 3:54 PM (IST)

Gufic BioSciences live price: ₹422.25. It opened at ₹442 vs previous close ₹440; intraday high/low: ₹442/₹421. The 50 & 200 DMA stand at ₹425.90/₹385.40.

Gufic BioSciences Performance

  • Today's Low
  • ₹421
  • Today's High
  • ₹442
  • 52 Week Low
  • ₹268
  • 52 Week High
  • ₹494
  • Open Price₹442
  • Previous Close₹440
  • Volume162,346
  • 50 DMA₹425.90
  • 100 DMA₹408.90
  • 200 DMA₹385.40

Gufic BioSciences Chart

Investment Returns

  • Over 1 Month + 4.39%
  • Over 3 Month + 0.2%
  • Over 6 Month + 52.38%
  • Over 1 Year + 28.19%

Smart Investing Starts Here Start SIP with Gufic BioSciences for Steady Growth!

Invest Now

Gufic BioSciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 52.9
  • PEG Ratio
  • 1.3
  • Market Cap Cr
  • 4,234
  • P/B Ratio
  • 6.2
  • Average True Range
  • 23
  • EPS
  • 8
  • Dividend Yield
  • 0
  • MACD Signal
  • 8.5
  • RSI
  • 46.03
  • MFI
  • 65.68

Latest Stock News Updates

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Intimation of Audio Recording of Earnings Conference Call held on November 16, 2026 at 04:30 p.m. is attached herewith

Q2FY27 Quarterly Result Announced for Gufic BioSciences Ltd.

<h3><span style="font-size:16px;"><strong>Pharmaceuticals company Gufic BioSciences announced Q2FY27 results</strong></span></h3> <p><strong>Consolidated Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAIChAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="gZfvmc_1l"> <li data-complete="true" data-hveid="CAAIChAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_1m"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_1o">Revenue from operations:<!--TgQPHd|||[]--></strong> In Q2FY27, consolidated revenue from operations stood at Rs 28,827.30 lakh, registering a growth of 10.53% QoQ from Rs 26,081.80 lakh in Q1FY27 and an increase of 21.61% YoY from Rs 23,705.45 lakh in Q2FY26. For H1FY27, consolidated revenue from operations grew by 19.17% YoY to Rs 54,909.10 lakh compared to Rs 46,077.70 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_1u"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_1w">Total income:<!--TgQPHd|||[]--></strong> In Q2FY27, consolidated total income stood at Rs 28,939.77 lakh, up 10.76% QoQ from Rs 26,127.55 lakh in Q1FY27 and up 21.00% YoY from Rs 23,917.00 lakh in Q2FY26. For H1FY27, consolidated total income rose by 18.73% YoY to Rs 55,067.32 lakh from Rs 46,381.77 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAH" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_22"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_24">Profit before tax (PBT):<!--TgQPHd|||[]--></strong> In Q2FY27, consolidated PBT increased by 4.69% QoQ to Rs 3,144.74 lakh from Rs 3,003.94 lakh in Q1FY27 and rose by 39.12% YoY from Rs 2,260.41 lakh in Q2FY26. For H1FY27, consolidated PBT grew by 54.19% YoY to Rs 6,148.68 lakh from Rs 3,987.82 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAK" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_2a"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_2c">Profit after tax (PAT):<!--TgQPHd|||[]--></strong> In Q2FY27, consolidated total profit for the period rose by 5.18% QoQ to Rs 2,346.89 lakh from Rs 2,231.28 lakh in Q1FY27 and increased by 39.50% YoY from Rs 1,682.40 lakh in Q2FY26. For H1FY27, consolidated total profit for the period grew by 53.14% YoY to Rs 4,578.17 lakh compared to Rs 2,989.44 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAN" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_2i"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_2k">Earnings per share (EPS):<!--TgQPHd|||[]--></strong> In Q2FY27, consolidated basic and diluted EPS rose by 5.41% QoQ to Rs 2.34 from Rs 2.22 in Q1FY27 and grew by 39.29% YoY from Rs 1.68 in Q2FY26. For H1FY27, consolidated basic and diluted EPS increased by 53.36% YoY to Rs 4.57 from Rs 2.98 in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <!--TgQPHd|||[]--> </ul> <p><!--TgQPHd|||[]--></p> <p><strong>Standalone Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAIDRAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="gZfvmc_2x"> <li data-complete="true" data-hveid="CAAIDRAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_2y"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_30">Revenue from operations:<!--TgQPHd|||[]--></strong> In Q2FY27, standalone revenue from operations stood at Rs 28,840.15 lakh, increasing by 10.58% QoQ from Rs 26,081.80 lakh in Q1FY27 and growing by 25.16% YoY from Rs 23,041.80 lakh in Q2FY26. For H1FY27, standalone revenue from operations rose by 20.09% YoY to Rs 54,921.95 lakh from Rs 45,732.95 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDRAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_36"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_38">Total income:<!--TgQPHd|||[]--></strong> In Q2FY27, standalone total income stood at Rs 28,952.62 lakh, up 10.81% QoQ from Rs 26,127.55 lakh in Q1FY27 and up 24.52% YoY from Rs 23,250.85 lakh in Q2FY26. For H1FY27, standalone total income grew by 19.66% YoY to Rs 55,080.17 lakh from Rs 46,031.42 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDRAH" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_3e"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_3g">Profit before tax (PBT):<!--TgQPHd|||[]--></strong> In Q2FY27, standalone PBT increased by 4.41% QoQ to Rs 3,149.25 lakh from Rs 3,016.20 lakh in Q1FY27 and rose by 53.41% YoY from Rs 2,052.86 lakh in Q2FY26. For H1FY27, standalone PBT surged by 67.51% YoY to Rs 6,165.45 lakh from Rs 3,680.56 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDRAK" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_3m"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_3o">Profit after tax (PAT):<!--TgQPHd|||[]--></strong> In Q2FY27, standalone total profit for the period rose by 4.58% QoQ to Rs 2,348.86 lakh from Rs 2,246.05 lakh in Q1FY27 and increased by 57.25% YoY from Rs 1,493.71 lakh in Q2FY26. For H1FY27, standalone total profit for the period jumped by 70.12% YoY to Rs 4,594.91 lakh from Rs 2,701.04 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDRAN" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_3u"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_3w">Earnings per share (EPS):<!--TgQPHd|||[]--></strong> In Q2FY27, standalone basic and diluted EPS increased by 4.46% QoQ to Rs 2.34 from Rs 2.24 in Q1FY27 and grew by 57.05% YoY from Rs 1.49 in Q2FY26. For H1FY27, standalone basic and diluted EPS rose by 70.26% YoY to Rs 4.58 from Rs 2.69 in H1FY26.</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5953353/" target="_blank">Result PDF</a></p>

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper advertisement of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026 is attached herewith

Gufic BioSciences Financials

Gufic BioSciences Technicals

EMA & SMA

Current Price
₹422.25
-17.6 (-4%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹437.20
  • 50 Day
  • ₹425.90
  • 100 Day
  • ₹408.90
  • 200 Day
  • ₹385.40

Resistance and Support

428.42 Pivot Speed
  • R3 456.80
  • R2 449.40
  • R1 435.80
  • S1 414.80
  • S2 407.40
  • S3 393.90

Gufic BioSciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-14 Quarterly Results
2026-08-14 Quarterly Results
2026-05-29 Audited Results & Final Dividend
2026-02-13 Quarterly Results
2025-11-14 Quarterly Results
Date Purpose Remarks
2026-08-28 FINAL Rs.0.10 per share(10%)Final Dividend
2025-09-22 FINAL Rs.0.10 per share(10%)Final Dividend
View Gufic BioSciences Dividend History Arrow
Date Purpose Remarks
2002-11-08 Split Face value changed from Rs. 10/- to Rs. 1/-

Gufic BioSciences Shareholding Pattern

72.5%
23.66%
3.03%
0.44%
0.35%

About Gufic BioSciences

Gufic BioSciences engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. View More
  • NSE Symbol
  • GUFICBIO
  • BSE Symbol
  • 509079
  • ISIN
  • INE742B01025

Similar Stocks to Gufic BioSciences

Gufic BioSciences FAQs

Gufic BioSciences share price is ₹422 As on 19 November, 2026 | 08:09

The Market Cap of Gufic BioSciences is ₹4234.4 Cr As on 19 November, 2026 | 08:09

The P/E ratio of Gufic BioSciences is 52.9 As on 19 November, 2026 | 08:09

The PB ratio of Gufic BioSciences is 6.2 As on 19 November, 2026 | 08:09

The 52 week High & Low of Gufic BioSciences is ₹494/₹268 respectively As on 19 November, 2026 | 08:09

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23